semaglutide aion The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added Risk of NAION Higher in
Description
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
A shelf-stable GLP-1 probiotic that actually reaches the intestine supports GI balance during treatment.*
Struggling with GLP-1 side effects
Discover the best Chick-fil-A healthy options and what to order for a balanced meal
FuturHealth and similar telehealth platforms offer compounded semaglutide through licensed pharmacies
If you're taking a GLP-1, you may not want to take it forever
